Apomorphine in patients with Parkinson's disease
Authors:
- E BroussolleEBE Broussolle
- G ChazotGCG Chazot
- 1 January 1995
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 49 (4) , 197-209
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Apomorphine infusional therapy in parkinson's disease: Clinical utility and lack of toleranceMovement Disorders, 1995
- Apomorphine in treatment of Parkinson's disease: comparison between subcutaneous and sublingual routes.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- Comparison of motor response to apomorphine and levodopa in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1990
- Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromesThe Lancet, 1990
- The short-duration response to apomorphine: Implications for the mechanism of dopaminergic effects in parkinsonismAnnals of Neurology, 1990
- SIDE-EFFECTS OF SUBCUTANEOUS APOMORPHINE IN PARKINSON'S DISEASEThe Lancet, 1989
- Subcutaneous apomorphine in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- SUBCUTANEOUS APOMORPHINE FOR ON-OFF OSCILLATIONS IN PARKINSON'S DISEASEThe Lancet, 1988
- SUBCUTANEOUS APOMORPHINE IN PARKINSON'S DISEASEThe Lancet, 1988
- Intermittent versus continuous stimulation: Effect of time interval on the development of sensitization or toleranceLife Sciences, 1980